2025 Cervical Cancer Diagnostics Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cervical Cancer Diagnostics Industry Market Size Be by 2025?
The market for cervical cancer diagnostics has seen robust growth in recent years. The market value is projected to rise from $9.27 billion in 2024 to $9.85 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The historic growth can be credited to factors such as heightened awareness and screening initiatives, HPV vaccinations, technological progress, and an aging population.

What's the Long-Term Growth Forecast for the Cervical Cancer Diagnostics Market Size Through 2029?
In the coming years, the market size for cervical cancer diagnostics is predicted to witness robust expansion, reaching a value of $12.5 billion in 2029, with a CAGR of 6.1%. This growth during the prediction period can be linked to a rise in hpv-related cancers, emerging markets, advancements in molecular testing, telemedicine, and remote screening. Prevailing trends for the forecast timeframe incorporate hpv testing, liquid-based cytology, automation, digital pathology, and screen-and-treat programs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

What Are the Key Growth Drivers Fueling the Cervical Cancer Diagnostics Market Expansion?
Expected growth in the cervical cancer diagnostics market is largely driven by the increasing uptake of cervical cancer diagnostic tests for early identification of the disease. The growing awareness of cervical cancer among women, reinforced by the emphasis placed by global cancer organizations and governments on early testing, adds to the market's expansion. To exemplify, the Centers for Disease Control and Prevention, a US government agency, reported in July 2024 that the US had recorded 12,536 new cervical cancer cases in 2021, which resulted in 4,051 fatalities among women in 2022. Thus, the growing acceptance of the diagnostic tests for cervical cancer and the focus on timely detection augments the progression of the cervical cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3285&type=smp

What Are the Key Trends Driving Cervical Cancer Diagnostics Market Growth?
Top cervical cancer diagnostics firms are putting their focus on the creation of cutting-edge solutions such as HPV self-collection procedures for cervical cancer to broaden the availability of screening and improve early detection. The HPV self-collection method permits individuals to gather their own samples for HPV testing, a prominent cause of cervical cancer. For example, in May 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical enterprise, earned FDA approval for its HPV self-collection solution, a substantial progression in cervical cancer screening that heightens accessibility for people, particularly those in underserved communities. This novel approach enables women to confidentially collect vaginal samples for analysis through Roche's Cobas HPV molecular test, contributing to the World Health Organization's objective of eradicating cervical cancer by 2030. The endorsement follows the successful IMPACT trial, which confirms the effectiveness of this solution across diverse demographics.

How Is the Cervical Cancer Diagnostics Market Segmented?
The cervical cancer diagnostics market covered in this report is segmented -

1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests
2) By Age Group: Below 21, Age between 21 to 29, Age between 30 to 65, Above 65
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Diagnostic Centers

Subsegments:
1) By Pap Smear Test: Conventional Pap Smear, Liquid-Based Pap Smear
2) By HPV Test: DNA-Based HPV Test, RNA-Based HPV Test, Hybrid Capture HPV Test, Other HPV Tests
3) By Colposcopy: Standard Colposcopy, Digital Colposcopy, Optical Colposcopy
4) By Biopsy And Endocervical Curettage: Punch Biopsy, Endocervical Curettage (ECC), Cone Biopsy, Colposcopic Biopsy
5) By Other Diagnostic Tests: Visual Inspection With Acetic Acid (VIA), Cervical Cytology Testing, Blood Tests, Other Specialty Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3285&type=smp

Which Companies Are Leading the Charge in Cervical Cancer Diagnostics Market Innovation?
Major companies operating in the cervical cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Zilico Ltd., Guided Therapeutics Inc., Thermo Fisher Scientific Inc., Carl Zeiss AG, OncoHealth Corporation, Arbor Vita Corporation, Micromedic Technologies Ltd., Trovagene Inc., Roche Diagnostics, Nucleix Ltd., BGI Genomics Co. Ltd., Cepheid, Exact Sciences Corporation, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., PerkinElmer Inc., Sysmex Corporation, Veracyte Inc., Zymo Research Corporation

Which Regions Are Leading the Global Cervical Cancer Diagnostics Market in Revenue?
North America was the largest region in the cervical cancer diagnostics market in 2023 Asia-Pacific was the second largest region in the cervical cancer diagnostics market. The regions covered in the cervical cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3285

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.